| Revenue growth | 22% YoY consolidated; -25% YoY standalone. |
|---|---|
| Margins | PAn margins improved; Fumaric Acid prices strengthened significantly. |
| Demand visibility | Steady domestic demand; growth in Paint and UPR segments. |
Growth
Consolidated revenue grew 22% YoY. Standalone PAT turned positive at INR 14 Cr vs loss of 14 Cr YoY.
Outlook
US facility (40.5 KTPA MAn) commercial operations targeted for Dec '26. Extension of anti-dumping duties supports domestic stability.
Risks
Chinese overcapacity in PAn, raw material shortages at Dahej, and high interest expenses at TCLS LLC, USA.
Investor Presentation filed with BSE, NSE: TIRUMALCHM. Summary written with AI assistance from the document.
Thirumalai Chemicals Ltd: key numbers
- Share price
- ₹160.93
- Market cap
- ₹1,940 Cr
- Revenue (annual)
- ₹1,736 Cr
- Net profit (annual)
- ₹-167.9 Cr
- P/E (TTM)
- -12.8×Sector 37.5×
- Promoter holding
- 37.13%+0.00% QoQ
- FII holding
- 1.46%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Thirumalai Chemicals Ltd
All →Thirumalai Chemicals Q1 FY27 Results: Net Loss of ₹43.7 Cr, Loss Narrows
Thirumalai Chemicals Ltd reported revenue from operations of ₹546.7 Cr (+21.5% YoY) and a net loss of ₹43.7 Cr for Q1 FY27.
- Key figure
- Net loss ₹43.7 Cr
Thirumalai Chemicals Q4 FY26 Results: Net Loss of ₹28 Cr, Loss Widens
Thirumalai Chemicals Ltd reported revenue from operations of ₹424.2 Cr (-18.9% YoY) and a net loss of ₹28 Cr for Q4 FY26.
- Key figure
- Net loss ₹28 Cr